Latest KTRA reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Stock Kintara Therapeutics
Kintara Therapeutics logo

Kintara Therapeutics KTRA

$ 0.3 13.76%
mail-toReport an Error

Country

 usaUSA

IPO year

 -

Industry

 -

Stock Exchange

 NASDAQ CAPITAL

CEO

 -

Employees in the company

 -

Shares

 1.62 M

Market Cap[1]

 $ 486 K

EBITDA (LTM)

 $ 75 K

P/E (LTM)

 -0.04

P/S (LTM)

 -

EPS (LTM)

 -4.06

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.